Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Biohaven Pharmaceutical Holding Co Ltd Share Price

BHVN

NYQ

$11.54

+$0.06

(0.52%)

Industry: Biotechnology Sector: Health Care

Biohaven Pharmaceutical Holding Co Ltd Analyst Forecast

Overview Returns Financials Ratios News FAQs

Biohaven Pharmaceutical Holding Co Ltd Share Price Chart

Biohaven Pharmaceutical Holding Co Ltd Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$1.52B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

1.48M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

3.54

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$7.48 L

$40.82 H

$11.54

About Biohaven Pharmaceutical Holding Co Ltd, Common Stock

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 that is in Phase 2 clinical trial for the treatment of migraines and pain disorders; BHV-1510, which is in Phase ½ trial that targets advanced or metastatic epithelial tumors; and BHV-8000, a product candidate that completed Phase 1 clinical trial for the treatment of Alzheimer's and Parkinson's disease, and multiple sclerosis, as well as prevention of amyloid-related imaging abnormalities. It is also developing BHV-1300, which in Phase 1 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 1 trial for IgA nephropathy; BHV-1100, which is in Phase 1 trial for multiple myeloma patients; BHV-1600, which is in Phase 1 trial for the treatment of peripartum cardiomyopathy; BHV-1310 that is in preclinical trial for the treatment of generalized myasthenia gravis and other acute exacerbations or flares; BHV-1530, which is in preclinical trial to treat urothelial cancer; BHV-1500 that is in preclinical trial for Hodgkin's lymphoma; and BHV-5500 that blocks glutamate signaling mediated by post-synaptic NMDA receptors. The company has strategic partnerships with Merus N.V., GeneQuantum Healthcare (Suzhou) Co. Ltd., Aimed Bio, Inc., Yale University, Katholieke Universiteit Leuven, Bristol Meyers Squibb, and Hangzhou Highlightll Pharmaceutical Co. Ltd. Biohaven Ltd. was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut. more

Industry: BiotechnologySector: Health Care

Biohaven Pharmaceutical Holding Co Ltd Stock Returns

Time Frame	BHVN	Sector	S&P500
1-Week Return	-2.55%	0.72%	-1.31%
1-Month Return	-9.46%	1.27%	0.78%
3-Month Return	21.48%	3.13%	3.46%
6-Month Return	-28.29%	15.81%	6.19%
1-Year Return	-70.86%	8.89%	11.68%
3-Year Return	-24.67%	20.79%	71.21%
5-Year Return	57.26%	35.89%	74.81%

Time Frame	BHVN	Sector	S&P500
1-Week Return	-74.00%	45.37%	-49.72%
1-Month Return	-70.15%	16.60%	9.91%
3-Month Return	120.15%	13.31%	14.79%
6-Month Return	-49.05%	34.67%	12.95%
1-Year Return	-70.86%	8.89%	11.68%
3-Year Return	-9.01%	6.50%	19.63%
5-Year Return	9.48%	6.33%	11.82%

Biohaven Pharmaceutical Holding Co Ltd Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	462.51M	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	72.00K	1.39M	1.39M	3.37M	3.92M	[{"date":"2020-12-31","value":1.84,"profit":true},{"date":"2021-12-31","value":35.51,"profit":true},{"date":"2022-12-31","value":35.33,"profit":true},{"date":"2023-12-31","value":85.88,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	(72.00K)	370.85M	(1.39M)	(3.37M)	(3.92M)	[{"date":"2020-12-31","value":-0.02,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.37,"profit":false},{"date":"2023-12-31","value":-0.91,"profit":false},{"date":"2024-12-31","value":-1.06,"profit":false}]
Gross Margin	-	80.18%	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	114.51M	218.90M	567.93M	436.05M	885.11M	[{"date":"2020-12-31","value":12.94,"profit":true},{"date":"2021-12-31","value":24.73,"profit":true},{"date":"2022-12-31","value":64.17,"profit":true},{"date":"2023-12-31","value":49.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(114.51M)	(218.90M)	(567.93M)	(436.05M)	(885.11M)	[{"date":"2020-12-31","value":-11450600000,"profit":false},{"date":"2021-12-31","value":-21890000000,"profit":false},{"date":"2022-12-31","value":-56793200000,"profit":false},{"date":"2023-12-31","value":-43605100000,"profit":false},{"date":"2024-12-31","value":-88511100000,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	(118.67M)	(212.43M)	(569.84M)	(409.55M)	(845.69M)	[{"date":"2020-12-31","value":-11866800000,"profit":false},{"date":"2021-12-31","value":-21243000000,"profit":false},{"date":"2022-12-31","value":-56984100000,"profit":false},{"date":"2023-12-31","value":-40955100000,"profit":false},{"date":"2024-12-31","value":-84568700000,"profit":false}]
Income Taxes	(134.00K)	1.37M	438.00K	(1.38M)	735.00K	[{"date":"2020-12-31","value":-9.81,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":32.06,"profit":true},{"date":"2023-12-31","value":-101.24,"profit":false},{"date":"2024-12-31","value":53.81,"profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(118.67M)	(848.40M)	(570.28M)	(408.17M)	(846.42M)	[{"date":"2020-12-31","value":-11866800000,"profit":false},{"date":"2021-12-31","value":-84839600000,"profit":false},{"date":"2022-12-31","value":-57027900000,"profit":false},{"date":"2023-12-31","value":-40816800000,"profit":false},{"date":"2024-12-31","value":-84642200000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(118.67M)	(213.80M)	(570.28M)	(408.17M)	(846.42M)	[{"date":"2020-12-31","value":-11866800000,"profit":false},{"date":"2021-12-31","value":-21379600000,"profit":false},{"date":"2022-12-31","value":-57027900000,"profit":false},{"date":"2023-12-31","value":-40816800000,"profit":false},{"date":"2024-12-31","value":-84642200000,"profit":false}]

EPS (Diluted)	(13.04)	(13.08)	(14.25)	(5.66)	(9.15)	[{"date":"2020-12-31","value":-1304,"profit":false},{"date":"2021-12-31","value":-1308,"profit":false},{"date":"2022-12-31","value":-1425,"profit":false},{"date":"2023-12-31","value":-566,"profit":false},{"date":"2024-12-31","value":-915,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	1834.72%	(0.50%)	143.07%	16.44%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.03,"profit":false},{"date":"2023-12-31","value":7.8,"profit":true},{"date":"2024-12-31","value":0.9,"profit":true}]
Gross Profit	-	(515162.50%)	(100.37%)	143.07%	16.44%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-360068.19,"profit":false},{"date":"2022-12-31","value":-70.16,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":11.49,"profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	91.17%	159.45%	(23.22%)	102.98%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":57.18,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-14.56,"profit":false},{"date":"2024-12-31","value":64.59,"profit":true}]
Operating Income	-	91.17%	159.45%	(23.22%)	102.98%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":57.18,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-14.56,"profit":false},{"date":"2024-12-31","value":64.59,"profit":true}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	-	79.01%	168.25%	(28.13%)	106.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":46.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-16.72,"profit":false},{"date":"2024-12-31","value":63.29,"profit":true}]
Income Taxes	-	(1119.40%)	(67.94%)	(415.75%)	(153.15%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Income After Taxes	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	614.93%	(32.78%)	(28.43%)	107.37%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-5.33,"profit":false},{"date":"2023-12-31","value":-4.62,"profit":false},{"date":"2024-12-31","value":17.46,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	80.16%	166.74%	(28.43%)	107.37%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":48.08,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.05,"profit":false},{"date":"2024-12-31","value":64.39,"profit":true}]

EPS (Diluted)	-	0.31%	8.94%	(60.28%)	61.66%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.5,"profit":true},{"date":"2022-12-31","value":14.51,"profit":true},{"date":"2023-12-31","value":-97.76,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	3.84M	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	1.00M	1.92M	1.01M	-	1.10M	[{"date":"2024-09-30","value":52.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":52.92,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":57.61,"profit":true}]
Gross Profit	(1.00M)	1.92M	(1.01M)	-	(1.10M)	[{"date":"2024-09-30","value":-52.14,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-52.92,"profit":false},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":-57.61,"profit":false}]
Gross Margin	-	50.00%	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	178.17M	189.93M	221.56M	211.70M	168.28M	[{"date":"2024-09-30","value":80.41,"profit":true},{"date":"2024-12-31","value":85.72,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":95.55,"profit":true},{"date":"2025-09-30","value":75.95,"profit":true}]
Operating Income	(178.17M)	(189.93M)	(221.56M)	(211.70M)	(169.38M)	[{"date":"2024-09-30","value":-17816800000,"profit":false},{"date":"2024-12-31","value":-18993100000,"profit":false},{"date":"2025-03-31","value":-22156100000,"profit":false},{"date":"2025-06-30","value":-21170100000,"profit":false},{"date":"2025-09-30","value":-16938200000,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Pre-Tax Income	(160.36M)	(186.79M)	(221.07M)	(197.89M)	(173.22M)	[{"date":"2024-09-30","value":-16036300000,"profit":false},{"date":"2024-12-31","value":-18679500000,"profit":false},{"date":"2025-03-31","value":-22106800000,"profit":false},{"date":"2025-06-30","value":-19788600000,"profit":false},{"date":"2025-09-30","value":-17322200000,"profit":false}]
Income Taxes	(59.00K)	48.00K	609.00K	261.00K	221.00K	[{"date":"2024-09-30","value":-9.69,"profit":false},{"date":"2024-12-31","value":7.88,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":42.86,"profit":true},{"date":"2025-09-30","value":36.29,"profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(160.30M)	(186.84M)	(221.68M)	(198.15M)	(173.44M)	[{"date":"2024-09-30","value":-16030400000,"profit":false},{"date":"2024-12-31","value":-18684300000,"profit":false},{"date":"2025-03-31","value":-22167700000,"profit":false},{"date":"2025-06-30","value":-19814700000,"profit":false},{"date":"2025-09-30","value":-17344300000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(160.30M)	(186.84M)	(221.68M)	(198.15M)	(173.44M)	[{"date":"2024-09-30","value":-16030400000,"profit":false},{"date":"2024-12-31","value":-18684300000,"profit":false},{"date":"2025-03-31","value":-22167700000,"profit":false},{"date":"2025-06-30","value":-19814700000,"profit":false},{"date":"2025-09-30","value":-17344300000,"profit":false}]

EPS (Diluted)	(1.74)	(1.71)	(2.17)	(1.94)	(1.64)	[{"date":"2024-09-30","value":-174,"profit":false},{"date":"2024-12-31","value":-171,"profit":false},{"date":"2025-03-31","value":-217,"profit":false},{"date":"2025-06-30","value":-194,"profit":false},{"date":"2025-09-30","value":-164,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	-	91.80%	(47.08%)	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-51.29,"profit":false},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	-	(291.80%)	(152.92%)	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	6.60%	16.65%	(4.45%)	(20.51%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":39.64,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-26.72,"profit":false},{"date":"2025-09-30","value":-123.17,"profit":false}]
Operating Income	-	6.60%	16.65%	(4.45%)	(19.99%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":39.64,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-26.72,"profit":false},{"date":"2025-09-30","value":-120.04,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Pre-Tax Income	-	16.48%	18.35%	(10.49%)	(12.46%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":89.83,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-57.15,"profit":false},{"date":"2025-09-30","value":-67.93,"profit":false}]
Income Taxes	-	(181.36%)	1168.75%	(57.14%)	(15.33%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-15.52,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-4.89,"profit":false},{"date":"2025-09-30","value":-1.31,"profit":false}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	16.56%	18.64%	(10.61%)	(12.47%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":88.8,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-56.93,"profit":false},{"date":"2025-09-30","value":-66.87,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	16.56%	18.64%	(10.61%)	(12.47%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":88.8,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-56.93,"profit":false},{"date":"2025-09-30","value":-66.87,"profit":false}]

EPS (Diluted)	-	(1.72%)	26.90%	(10.60%)	(15.46%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.41,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-39.4,"profit":false},{"date":"2025-09-30","value":-57.49,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	89.76M	94.82M	586.97M	442.45M	538.47M	[{"date":"2020-12-31","value":15.29,"profit":true},{"date":"2021-12-31","value":16.15,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":75.38,"profit":true},{"date":"2024-12-31","value":91.74,"profit":true}]
Non-current Assets	21.74M	47.24M	74.81M	70.77M	76.64M	[{"date":"2020-12-31","value":28.37,"profit":true},{"date":"2021-12-31","value":61.64,"profit":true},{"date":"2022-12-31","value":97.63,"profit":true},{"date":"2023-12-31","value":92.34,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	111.50M	142.06M	661.78M	513.21M	615.11M	[{"date":"2020-12-31","value":16.85,"profit":true},{"date":"2021-12-31","value":21.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":77.55,"profit":true},{"date":"2024-12-31","value":92.95,"profit":true}]

Total Liabilities
Current Liabilities	29.88M	41.94M	90.02M	55.42M	154.23M	[{"date":"2020-12-31","value":19.37,"profit":true},{"date":"2021-12-31","value":27.19,"profit":true},{"date":"2022-12-31","value":58.37,"profit":true},{"date":"2023-12-31","value":35.94,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	4.84M	5.43M	32.99M	29.81M	37.45M	[{"date":"2020-12-31","value":12.93,"profit":true},{"date":"2021-12-31","value":14.51,"profit":true},{"date":"2022-12-31","value":88.11,"profit":true},{"date":"2023-12-31","value":79.62,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	34.72M	47.37M	123.01M	85.24M	191.67M	[{"date":"2020-12-31","value":18.11,"profit":true},{"date":"2021-12-31","value":24.71,"profit":true},{"date":"2022-12-31","value":64.18,"profit":true},{"date":"2023-12-31","value":44.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.25B	1.68B	615.74M	887.53M	1.66B	[{"date":"2020-12-31","value":74.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":36.72,"profit":true},{"date":"2023-12-31","value":52.93,"profit":true},{"date":"2024-12-31","value":98.8,"profit":true}]
Retained Earnings	(1.74B)	(2.59B)	(91.12M)	(499.29M)	(1.35B)	[{"date":"2020-12-31","value":-173916900000,"profit":false},{"date":"2021-12-31","value":-258575500000,"profit":false},{"date":"2022-12-31","value":-9112400000,"profit":false},{"date":"2023-12-31","value":-49929200000,"profit":false},{"date":"2024-12-31","value":-134571400000,"profit":false}]
Other Stockholders' Equity	98.94M	169.66M	13.87M	39.80M	112.37M	[{"date":"2020-12-31","value":58.32,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.17,"profit":true},{"date":"2023-12-31","value":23.46,"profit":true},{"date":"2024-12-31","value":66.23,"profit":true}]
Total Shareholders' equity	16.78M	34.69M	538.77M	427.98M	423.44M	[{"date":"2020-12-31","value":3.11,"profit":true},{"date":"2021-12-31","value":6.44,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.44,"profit":true},{"date":"2024-12-31","value":78.59,"profit":true}]

Total Liabilities & Shareholders Equity	51.50M	82.06M	661.78M	513.21M	615.11M	[{"date":"2020-12-31","value":7.78,"profit":true},{"date":"2021-12-31","value":12.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":77.55,"profit":true},{"date":"2024-12-31","value":92.95,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	5.65%	519.01%	(24.62%)	21.70%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":1.09,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4.74,"profit":false},{"date":"2024-12-31","value":4.18,"profit":true}]
Non-current Assets	-	117.26%	58.38%	(5.41%)	8.29%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":49.79,"profit":true},{"date":"2023-12-31","value":-4.62,"profit":false},{"date":"2024-12-31","value":7.07,"profit":true}]
Total Assets	-	27.41%	365.84%	(22.45%)	19.85%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":7.49,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-6.14,"profit":false},{"date":"2024-12-31","value":5.43,"profit":true}]

Total Liabilities
Current Liabilities	-	40.36%	114.67%	(38.43%)	178.27%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":22.64,"profit":true},{"date":"2022-12-31","value":64.32,"profit":true},{"date":"2023-12-31","value":-21.56,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	12.27%	507.01%	(9.63%)	25.60%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":2.42,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.9,"profit":false},{"date":"2024-12-31","value":5.05,"profit":true}]
Total Liabilities	-	36.44%	159.68%	(30.71%)	124.87%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":22.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-19.23,"profit":false},{"date":"2024-12-31","value":78.2,"profit":true}]

Total Shareholders' equity
Common Stock	-	34.19%	(63.28%)	44.14%	86.66%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":39.45,"profit":true},{"date":"2022-12-31","value":-73.02,"profit":false},{"date":"2023-12-31","value":50.93,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	48.68%	(96.48%)	447.93%	169.52%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":10.87,"profit":true},{"date":"2022-12-31","value":-21.54,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":37.85,"profit":true}]
Other Stockholders' Equity	-	71.48%	(91.83%)	187.00%	182.31%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":38.22,"profit":true},{"date":"2022-12-31","value":-49.1,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":97.49,"profit":true}]
Total Shareholders' equity	-	106.73%	1453.06%	(20.56%)	(1.06%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":7.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.42,"profit":false},{"date":"2024-12-31","value":-0.07,"profit":false}]

Total Liabilities & Shareholders Equity	-	59.34%	706.45%	(22.45%)	19.85%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":8.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3.18,"profit":false},{"date":"2024-12-31","value":2.81,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	440.50M	538.47M	382.76M	474.83M	323.62M	[{"date":"2024-09-30","value":81.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":71.08,"profit":true},{"date":"2025-06-30","value":88.18,"profit":true},{"date":"2025-09-30","value":60.1,"profit":true}]
Non-current Assets	70.02M	76.64M	76.19M	75.59M	85.51M	[{"date":"2024-09-30","value":81.89,"profit":true},{"date":"2024-12-31","value":89.62,"profit":true},{"date":"2025-03-31","value":89.1,"profit":true},{"date":"2025-06-30","value":88.4,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	510.52M	615.11M	458.95M	550.41M	409.12M	[{"date":"2024-09-30","value":83,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":74.61,"profit":true},{"date":"2025-06-30","value":89.48,"profit":true},{"date":"2025-09-30","value":66.51,"profit":true}]

Total Liabilities
Current Liabilities	152.29M	154.23M	164.03M	124.32M	113.02M	[{"date":"2024-09-30","value":92.84,"profit":true},{"date":"2024-12-31","value":94.02,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":75.79,"profit":true},{"date":"2025-09-30","value":68.9,"profit":true}]
Non-current Liabilities	42.22M	37.45M	35.42M	291.50M	313.26M	[{"date":"2024-09-30","value":13.48,"profit":true},{"date":"2024-12-31","value":11.95,"profit":true},{"date":"2025-03-31","value":11.31,"profit":true},{"date":"2025-06-30","value":93.05,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	194.52M	191.67M	199.45M	415.83M	426.28M	[{"date":"2024-09-30","value":45.63,"profit":true},{"date":"2024-12-31","value":44.96,"profit":true},{"date":"2025-03-31","value":46.79,"profit":true},{"date":"2025-06-30","value":97.55,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.38B	1.66B	1.69B	1.74B	1.74B	[{"date":"2024-09-30","value":79.24,"profit":true},{"date":"2024-12-31","value":95.01,"profit":true},{"date":"2025-03-31","value":96.88,"profit":true},{"date":"2025-06-30","value":99.96,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(1.16B)	(1.35B)	(1.57B)	(1.77B)	(1.94B)	[{"date":"2024-09-30","value":-115887100000,"profit":false},{"date":"2024-12-31","value":-134571400000,"profit":false},{"date":"2025-03-31","value":-156739100000,"profit":false},{"date":"2025-06-30","value":-176553800000,"profit":false},{"date":"2025-09-30","value":-193898100000,"profit":false}]
Other Stockholders' Equity	93.04M	112.37M	137.47M	157.02M	178.04M	[{"date":"2024-09-30","value":52.26,"profit":true},{"date":"2024-12-31","value":63.11,"profit":true},{"date":"2025-03-31","value":77.21,"profit":true},{"date":"2025-06-30","value":88.19,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	316.01M	423.44M	259.50M	134.59M	(17.16M)	[{"date":"2024-09-30","value":74.63,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":61.28,"profit":true},{"date":"2025-06-30","value":31.78,"profit":true},{"date":"2025-09-30","value":-4.05,"profit":false}]

Total Liabilities & Shareholders Equity	510.52M	615.11M	458.95M	550.41M	409.12M	[{"date":"2024-09-30","value":83,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":74.61,"profit":true},{"date":"2025-06-30","value":89.48,"profit":true},{"date":"2025-09-30","value":66.51,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	22.24%	(28.92%)	24.05%	(31.85%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":92.46,"profit":true},{"date":"2025-03-31","value":-120.22,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-132.39,"profit":false}]
Non-current Assets	-	9.44%	(0.58%)	(0.79%)	13.12%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":71.96,"profit":true},{"date":"2025-03-31","value":-4.43,"profit":false},{"date":"2025-06-30","value":-6.01,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	-	20.49%	(25.39%)	19.93%	(25.67%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-123.93,"profit":false},{"date":"2025-06-30","value":97.29,"profit":true},{"date":"2025-09-30","value":-125.31,"profit":false}]

Total Liabilities
Current Liabilities	-	1.27%	6.36%	(24.21%)	(9.09%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":19.95,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-380.67,"profit":false},{"date":"2025-09-30","value":-142.94,"profit":false}]
Non-current Liabilities	-	(11.32%)	(5.42%)	723.06%	7.46%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.57,"profit":false},{"date":"2025-03-31","value":-0.75,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":1.03,"profit":true}]
Total Liabilities	-	(1.46%)	4.06%	108.49%	2.51%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.35,"profit":false},{"date":"2025-03-31","value":3.74,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":2.32,"profit":true}]

Total Shareholders' equity
Common Stock	-	19.90%	1.97%	3.18%	0.04%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":9.9,"profit":true},{"date":"2025-06-30","value":15.99,"profit":true},{"date":"2025-09-30","value":0.18,"profit":true}]
Retained Earnings	-	16.12%	16.47%	12.64%	9.82%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":97.88,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":76.74,"profit":true},{"date":"2025-09-30","value":59.64,"profit":true}]
Other Stockholders' Equity	-	20.78%	22.34%	14.22%	13.39%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":93.03,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":63.68,"profit":true},{"date":"2025-09-30","value":59.95,"profit":true}]
Total Shareholders' equity	-	34.00%	(38.72%)	(48.14%)	(112.75%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-113.89,"profit":false},{"date":"2025-06-30","value":-141.59,"profit":false},{"date":"2025-09-30","value":-331.66,"profit":false}]

Total Liabilities & Shareholders Equity	-	20.49%	(25.39%)	19.93%	(25.67%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-123.93,"profit":false},{"date":"2025-06-30","value":97.29,"profit":true},{"date":"2025-09-30","value":-125.31,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(75.96M)	(145.84M)	(297.69M)	(331.73M)	(582.45M)	[{"date":"2020-12-31","value":-7595700000,"profit":false},{"date":"2021-12-31","value":-14584000000,"profit":false},{"date":"2022-12-31","value":-29768900000,"profit":false},{"date":"2023-12-31","value":-33172500000,"profit":false},{"date":"2024-12-31","value":-58245300000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(2.70M)	944.00K	(304.79M)	129.83M	(244.97M)	[{"date":"2020-12-31","value":-2.08,"profit":false},{"date":"2021-12-31","value":0.73,"profit":true},{"date":"2022-12-31","value":-234.76,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-188.69,"profit":false}]

Financing Activities
Net Financing Cash Flow	152.24M	138.45M	767.60M	211.91M	677.77M	[{"date":"2020-12-31","value":19.83,"profit":true},{"date":"2021-12-31","value":18.04,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.61,"profit":true},{"date":"2024-12-31","value":88.3,"profit":true}]

Net Change in Cash	73.59M	(6.45M)	165.55M	9.52M	(149.58M)	[{"date":"2020-12-31","value":44.45,"profit":true},{"date":"2021-12-31","value":-3.9,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.75,"profit":true},{"date":"2024-12-31","value":-90.35,"profit":false}]

Free Cash Flow
Free Cash Flow	(78.65M)	(146.78M)	(338.76M)	(334.77M)	(586.50M)	[{"date":"2020-12-31","value":-7865400000,"profit":false},{"date":"2021-12-31","value":-14677800000,"profit":false},{"date":"2022-12-31","value":-33876300000,"profit":false},{"date":"2023-12-31","value":-33477300000,"profit":false},{"date":"2024-12-31","value":-58650200000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	92.00%	104.12%	11.43%	75.58%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":88.36,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":10.98,"profit":true},{"date":"2024-12-31","value":72.59,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(135.00%)	(32387.08%)	(142.60%)	(288.69%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(9.06%)	454.43%	(72.39%)	219.84%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.99,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-15.93,"profit":false},{"date":"2024-12-31","value":48.38,"profit":true}]

Net Change in Cash	-	(108.76%)	(2667.02%)	(94.25%)	(1671.86%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	86.61%	130.80%	(1.18%)	75.19%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":66.22,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-0.9,"profit":false},{"date":"2024-12-31","value":57.49,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(141.28M)	(170.74M)	(165.12M)	(167.94M)	(145.72M)	[{"date":"2024-09-30","value":-14127600000,"profit":false},{"date":"2024-12-31","value":-17074200000,"profit":false},{"date":"2025-03-31","value":-16512400000,"profit":false},{"date":"2025-06-30","value":-16793600000,"profit":false},{"date":"2025-09-30","value":-14571600000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(93.40M)	(87.68M)	164.88M	(15.55M)	164.97M	[{"date":"2024-09-30","value":-56.62,"profit":false},{"date":"2024-12-31","value":-53.15,"profit":false},{"date":"2025-03-31","value":99.95,"profit":true},{"date":"2025-06-30","value":-9.42,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	80.38M	272.85M	369.00K	249.83M	122.00K	[{"date":"2024-09-30","value":29.46,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":0.14,"profit":true},{"date":"2025-06-30","value":91.56,"profit":true},{"date":"2025-09-30","value":0.04,"profit":true}]

Net Change in Cash	(154.30M)	14.52M	147.00K	66.31M	19.39M	[{"date":"2024-09-30","value":-232.7,"profit":false},{"date":"2024-12-31","value":21.9,"profit":true},{"date":"2025-03-31","value":0.22,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":29.24,"profit":true}]

Free Cash Flow
Free Cash Flow	(141.89M)	(170.79M)	(165.59M)	(168.17M)	(145.73M)	[{"date":"2024-09-30","value":-14188700000,"profit":false},{"date":"2024-12-31","value":-17079100000,"profit":false},{"date":"2025-03-31","value":-16558500000,"profit":false},{"date":"2025-06-30","value":-16816900000,"profit":false},{"date":"2025-09-30","value":-14572900000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	20.86%	(3.29%)	1.70%	(13.23%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-15.78,"profit":false},{"date":"2025-06-30","value":8.16,"profit":true},{"date":"2025-09-30","value":-63.44,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(6.13%)	(288.05%)	(109.43%)	(1161.15%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	239.47%	(99.86%)	67604.61%	(99.95%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.35,"profit":true},{"date":"2025-03-31","value":-0.15,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.15,"profit":false}]

Net Change in Cash	-	(109.41%)	(98.99%)	45007.48%	(70.76%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-0.24,"profit":false},{"date":"2025-03-31","value":-0.22,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.16,"profit":false}]

Free Cash Flow
Free Cash Flow	-	20.37%	(3.05%)	1.56%	(13.34%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-14.96,"profit":false},{"date":"2025-06-30","value":7.66,"profit":true},{"date":"2025-09-30","value":-65.5,"profit":false}]

Biohaven Pharmaceutical Holding Co Ltd Ratios

Biohaven Pharmaceutical Holding Co Ltd Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	BHVN
Cash Ratio	2.30
Current Ratio	2.86

Biohaven Pharmaceutical Holding Co Ltd Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BHVN
ROA (LTM)	-106.25%
ROE (LTM)	-522.08%

Biohaven Pharmaceutical Holding Co Ltd Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	BHVN
Debt Ratio Lower is generally better. Negative is bad.	1.04
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-0.04

Biohaven Pharmaceutical Holding Co Ltd Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BHVN
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	12.19
Price/FCF	NM
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Biohaven Pharmaceutical Holding Co Ltd share price today?

Biohaven Pharmaceutical Holding Co Ltd (BHVN) share price today is $11.54

Can Indians buy Biohaven Pharmaceutical Holding Co Ltd shares?

Yes, Indians can buy shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BHVN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biohaven Pharmaceutical Holding Co Ltd be purchased?

Yes, you can purchase fractional shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) via the Vested app. You can start investing in Biohaven Pharmaceutical Holding Co Ltd (BHVN) with a minimum investment of $1.

How to invest in Biohaven Pharmaceutical Holding Co Ltd shares from India?

You can invest in shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) via Vested in three simple steps:

Click on Sign Up or Invest in BHVN stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Biohaven Pharmaceutical Holding Co Ltd shares

What is Biohaven Pharmaceutical Holding Co Ltd 52-week high and low stock price?

The 52-week high price of Biohaven Pharmaceutical Holding Co Ltd (BHVN) is $40.82. The 52-week low price of Biohaven Pharmaceutical Holding Co Ltd (BHVN) is $7.48.

What is Biohaven Pharmaceutical Holding Co Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biohaven Pharmaceutical Holding Co Ltd (BHVN) is

What is Biohaven Pharmaceutical Holding Co Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biohaven Pharmaceutical Holding Co Ltd (BHVN) is 12.19

What is Biohaven Pharmaceutical Holding Co Ltd dividend yield?

The dividend yield of Biohaven Pharmaceutical Holding Co Ltd (BHVN) is 0.00%

What is the Market Cap of Biohaven Pharmaceutical Holding Co Ltd?

The market capitalization of Biohaven Pharmaceutical Holding Co Ltd (BHVN) is $1.52B

What is Biohaven Pharmaceutical Holding Co Ltd's stock symbol?

The stock symbol (or ticker) of Biohaven Pharmaceutical Holding Co Ltd is BHVN

How Can Investors Use Biohaven Pharmaceutical Holding Co Ltd Share Price Data for Long-Term Investment Decisions?

Consider the share price of Biohaven Pharmaceutical Holding Co Ltd as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Biohaven Pharmaceutical Holding Co Ltd has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Biohaven Pharmaceutical Holding Co Ltd shares for Indian investors?

When investing in Biohaven Pharmaceutical Holding Co Ltd shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Biohaven Pharmaceutical Holding Co Ltd stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Biohaven Pharmaceutical Holding Co Ltd share price with other stocks in the same sector?

Rather than merely checking the share price of Biohaven Pharmaceutical Holding Co Ltd and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Biohaven Pharmaceutical Holding Co Ltd stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Biohaven Pharmaceutical Holding Co Ltd Share Price

Biohaven Pharmaceutical Holding Co Ltd Analyst Forecast

Biohaven Pharmaceutical Holding Co Ltd Share Price Chart

Biohaven Pharmaceutical Holding Co Ltd Key Stock Metrics

About Biohaven Pharmaceutical Holding Co Ltd, Common Stock

Biohaven Pharmaceutical Holding Co Ltd Stock Returns

Biohaven Pharmaceutical Holding Co Ltd Financials

Biohaven Pharmaceutical Holding Co Ltd Ratios

Biohaven Pharmaceutical Holding Co Ltd Liquidity Ratios

Biohaven Pharmaceutical Holding Co Ltd Asset Efficiency Ratios

Biohaven Pharmaceutical Holding Co Ltd Liability Ratios

Biohaven Pharmaceutical Holding Co Ltd Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Biohaven Pharmaceutical Holding Co Ltd Share Price

Biohaven Pharmaceutical Holding Co Ltd Analyst Forecast

Biohaven Pharmaceutical Holding Co Ltd Share Price Chart

Biohaven Pharmaceutical Holding Co Ltd Key Stock Metrics

About Biohaven Pharmaceutical Holding Co Ltd, Common Stock

Biohaven Pharmaceutical Holding Co Ltd Stock Returns

Biohaven Pharmaceutical Holding Co Ltd Financials

Biohaven Pharmaceutical Holding Co Ltd Ratios

Biohaven Pharmaceutical Holding Co Ltd Liquidity Ratios

Biohaven Pharmaceutical Holding Co Ltd Asset Efficiency Ratios

Biohaven Pharmaceutical Holding Co Ltd Liability Ratios

Biohaven Pharmaceutical Holding Co Ltd Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²